Stockreport

Citius Pharma (CTXR) Becomes Revenue-Generating With the Commercial Launch of LYMPHIR [Yahoo! Finance]

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com
PDF Citius Pharmaceuticals Inc. (NASDAQ: CTXR ) is one of the stocks that should double in 3 years . On February 13, Citius Pharmaceuticals officially transitioned into a r [Read more]